A critical discovery in cancer study is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial tumor protector protein is frequently inactivated in several forms of malignancies, leading https://webookmarks.com/story7622103/mini-antibodies-revive-the-p53-protein-the-promising-approach-for-cancer-therapy